Cardiovascular
Cumulative exposure to high remnant-cholesterol concentrations increases the risk of cardiovascular disease in patients with hypertension: a prospective cohort study
Sep
Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, et al. Heart Disease and Stroke Statistics-2020 update: a Report from the American Heart Association. Circulation. 2020;141(9):e139–e596.
Google Scholar
Sheng-Shou HU. Report on cardiovascular health and diseases in China 2021: an updated summary. Biomed Environ Sci. 2022;35(7):573–603.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies C. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–13.
Google Scholar
Zengwu Wang M, Chen Z, Zhang L, Wang Hao G, William PZZ, Weintraub S, Gao Runlin. Status of hypertension in China: results from the China hypertension survey, 2012–2015. Circulationaha. 2018. https://doi.org/10.1161/CIRCULATIONAHA.117.032380.
Google Scholar
Mortensen MB, Dzaye O, Botker HE, Jensen JM, Maeng M, Bentzen JF, Kanstrup H, Sorensen HT, Leipsic J, Blankstein R, et al. Low-Density lipoprotein cholesterol is predominantly associated with atherosclerotic cardiovascular disease events in patients with evidence of coronary atherosclerosis: the western denmark heart registry. Circulation. 2023. https://doi.org/10.1161/CIRCULATIONAHA.122.061010.
Google Scholar
Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, et al. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018;379(22):2097–107.
Google Scholar
Hirano T. Residual risk still remains in low-density lipoprotein. J Atheroscler Thromb. 2022;29(10):1425–6.
Google Scholar
Bruemmer D, Cho L. Remnant cholesterol: the leftovers and their contribution to atherosclerotic cardiovascular disease. Circ Cardiovasc Imaging. 2021;14(4):e012615.
Google Scholar
Cheang I, Zhu X, Lu X, Shi S, Tang Y, Yue X, Liao S, Yao W, Zhou Y, Zhang H, et al. Association of remnant cholesterol and non-high density lipoprotein cholesterol with risk of cardiovascular mortality among US general population. Heliyon. 2022;8(8):e10050.
Google Scholar
Jepsen AM, Langsted A, Varbo A, Bang LE, Kamstrup PR, Nordestgaard BG. Increased remnant cholesterol explains part of residual risk of all-cause mortality in 5414 patients with ischemic heart disease. Clin Chem. 2016;62(4):593–604.
Google Scholar
Wu Z, Wang J, Zhang H, Pan H, Li Z, Liu Y, Miao X, Han Z, Kang X, Li X, et al. Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond LDL cholesterol. BMC Med. 2023;21(1):42.
Google Scholar
Cao YX, Zhang HW, Jin JL, Liu HH, Zhang Y, Gao Y, Guo YL, Wu NQ, Hua Q, Li YF, et al. The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes. Cardiovasc Diabetol. 2020;19(1):104.
Google Scholar
Chen MM, Huang X, Xu C, Song XH, Liu YM, Yao D, Lu H, Wang G, Zhang GL, Chen Z, et al. High remnant cholesterol level potentiates the development of hypertension. Front Endocrinol 2022;13:830347.
Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, Pais P, López-Jaramillo P, Leiter LA, Dans A, et al. Cholesterol lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med. 2016;374(21):2021–31.
Google Scholar
Wang X, Feng B, Huang Z, Cai Z, Yu X, Chen Z, Cai Z, Chen G, Wu S, Chen Y. Relationship of cumulative exposure to the triglyceride-glucose index with ischemic stroke: a 9-year prospective study in the Kailuan cohort. Cardiovasc Diabetol. 2022;21(1):66.
Google Scholar
Li W, Huang Z, Fang W, Wang X, Cai Z, Chen G, Wu W, Chen Z, Wu S, Chen Y. Remnant cholesterol variability and incident ischemic stroke in the General Population. Stroke. 2022;53(6):1934–41.
Google Scholar
Wu S, Huang Z, Yang X, Zhou Y, Wang A, Chen L, Zhao H, Ruan C, Wu Y, Xin A, et al. Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern chinese industrial city. Circ Cardiovasc Qual Outcomes. 2012;5(4):487–93.
Google Scholar
Pool LR, Ning H, Wilkins J, Lloyd-Jones DM, Allen NB. Use of long-term cumulative blood pressure in cardiovascular risk prediction models. JAMA Cardiol. 2018;3(11):1096–100.
Google Scholar
Huang Y, Zhou H, Zhang S, Zhong X, Lin Y, Xiong Z, Liu M, Yimamu A, Christopher O, Zhou Z, et al. Mid- to late-life time-averaged cumulative blood pressure and late-life retinal microvasculature: the ARIC Study. J Am Heart Assoc. 2022;11(15):e25226.
Google Scholar
Joint Committee for Guideline R. 2018 chinese guidelines for prevention and treatment of hypertension-a report of the revision committee of Chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol. 2019;16(3):182–241.
Genuth S. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26(11):3160–7.
Google Scholar
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):3168–209.
Google Scholar
Wang X, Chen Y, Huang Z, Cai Z, Yu X, Chen Z, Li L, Chen G, Wu K, Zheng H, et al. Visit-to-visit variability in triglyceride-glucose index and diabetes: a 9-year prospective study in the Kailuan Study. Front Endocrinol. 2022;13:1054741.
Li W, Jin C, Vaidya A, Wu Y, Rexrode K, Zheng X, Gurol ME, Ma C, Wu S, Gao X. Blood pressure trajectories and the risk of Intracerebral Hemorrhage and cerebral infarction: a prospective study. Hypertension. 2017;70(3):508–14.
Google Scholar
Jin C, Chen S, Vaidya A, Wu Y, Wu Z, Hu FB, Kris-Etherton P, Wu S, Gao X. Longitudinal change in fasting blood glucose and myocardial infarction risk in a population without diabetes. Diabetes Care. 2017;40(11):1565–72.
Google Scholar
Huang Z, Chen Z, Wang X, Ding X, Cai Z, Li W, Cai Z, Lan Y, Chen G, Fang W, et al. Association of Cardiovascular Health score trajectory with Incident Myocardial Infarction in Hypertensive Patients. Hypertension. 2022;79(11):2622–30.
Google Scholar
Wu J, Chen S, Zhou Y, Wang C, Wang A, Zhang Q, Gao X, Hu H, Wu S, Zhao X. Non-high-density lipoprotein cholesterol on the risks of stroke: a result from the kailuan study. PLoS ONE. 2013;8(9):e74634.
Google Scholar
Yang X. Predicting the 10-Year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR Project (Prediction for ASCVD Risk in China). Circulation. 2016;134(19):1430–40.
Google Scholar
Han C, Liu F, Yang X, Chen J, Li J, Cao J, Li Y, Shen C, Yu L, Liu Z, et al. Ideal cardiovascular health and incidence of atherosclerotic cardiovascular disease among chinese adults: the China-PAR project. Sci China Life Sci. 2018;61(5):504–14.
Google Scholar
Delialis D, Georgiopoulos G, Aivalioti E, Mavraganis G, Dimopoulou AM, Sianis A, Aggelidakis L, Patras R, Petropoulos I, Ioannou S, et al. Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients. Beyond LDL cholesterol and hypolipidemic treatment. Hellenic J Cardiol. 2022;66:26–31.
Google Scholar
Hao QY, Gao JW, Yuan ZM, Gao M, Wang JF, Schiele F, Zhang SL, Liu PM. Remnant cholesterol and the risk of coronary artery calcium progression: insights from the CARDIA and MESA Study. Circ Cardiovasc Imaging. 2022;15(7):e014116.
Google Scholar
Burnett JR, Hooper AJ, Hegele RA. Remnant cholesterol and atherosclerotic cardiovascular disease risk. J Am Coll Cardiol. 2020;76(23):2736–9.
Google Scholar
Fu L, Tai S, Sun J, Zhang N, Zhou Y, Xing Z, Wang Y, Zhou S. Remnant cholesterol and its visit-to-visit variability predict cardiovascular outcomes in patients with type 2 diabetes: findings from the ACCORD Cohort. Diabetes Care. 2022;45(9):2136–43.
Google Scholar
Huh JH, Han KD, Cho YK, Roh E, Kang JG, Lee SJ, Ihm SH. Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study. Cardiovasc Diabetol. 2022;21(1):228.
Google Scholar
Wadstrom BN, Wulff AB, Pedersen KM, Jensen GB, Nordestgaard BG. Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study. Eur Heart J. 2022;43(34):3258–69.
Google Scholar
Hagg-Holmberg S, Dahlstrom EH, Forsblom CM, Harjutsalo V, Liebkind R, Putaala J, Tatlisumak T, Groop PH, Thorn LM, FinnDiane Study G. The role of blood pressure in risk of ischemic and hemorrhagic stroke in type 1 diabetes. Cardiovasc Diabetol. 2019;18(1):88.
Google Scholar
Jin X, Chen H, Shi H, Fu K, Li J, Tian L, Teng W. Lipid levels and the risk of hemorrhagic stroke: a dose-response meta-analysis. Nutr Metab Cardiovasc Dis. 2021;31(1):23–35.
Google Scholar
Vallejo-Vaz AJ. Triglyceride-Rich lipoprotein cholesterol and risk of cardiovascular events among patients receiving statin therapy in the TNT Trial. Circulation. 2018;138(8):770–81.
Google Scholar
Dallinga-Thie GM, Kroon J, Boren J, Chapman MJ. Triglyceride-Rich Lipoproteins and Remnants: targets for Therapy? Curr Cardiol Rep. 2016;18(7):67.
Google Scholar
Zheng XY, Liu L. Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase. J Lipid Res. 2007;48(8):1673–80.
Google Scholar
Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J, Kotite L, Kunitake ST, Havel RJ, Kane JP. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb. 1994;14(11):1767–74.
Google Scholar
Whitman SC. Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation. Arterioscl Thromb Vas Biol. 1997;17(9):1707–15.
Google Scholar
Varbo A, Benn M, Tybjaerg-Hansen A, Nordestgaard BG. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation. 2013;128(12):1298–309.
Google Scholar
Mottl, AKea. Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet Med. 2008;10(8):560–74.
Camargo LL, Montezano AC, Hussain M, Wang Y, Zou Z, Rios FJ, Neves KB, Alves-Lopes R, Awan FR, Guzik TJ, et al. Central role of c-Src in NOX5- mediated redox signalling in vascular smooth muscle cells in human hypertension. Cardiovasc Res. 2022;118(5):1359–73.
Google Scholar
Touyz RM, Alves-Lopes R, Rios FJ, Camargo LL, Anagnostopoulou A, Arner A, Montezano AC. Vascular smooth muscle contraction in hypertension. Cardiovasc Res. 2018;114(4):529–39.
Google Scholar
